Popular in Biomedical Engineering


Bright Ferritin – a Reporter Gene Platform

Employing nanotechnology to reduce cancer metastasis

Embed Cite Participate Recommend

Michael King is Professor of Biomedical Engineering at Cornell. The King lab is currently testing novel cancer therapies in mouse models of metastatic breast and prostate cancer through the use of whole body luminescence imaging. This work will uncover new therapeutic targets designed to prevent metastasis.

Image courtesy of interviewee

Log-in or Sign-up to Faculti
Currently viewing as guest. You have insight(s) remaining for this month.

Leave a Reply

Your email address will not be published.

Copyright © Faculti Media Limited 2023. All rights reserved.
Recommend Faculti to your librarian

Thousands of engaging insights, delivered at the world's leading institutions. 
Librarians welcome and value students, faculty and staff recommendations, and we aim to facilitate these suggestions in an impactful way.

error: